Scinex Corporation
Scinex Corporation (2376.T) Financial Performance & Income Statement Overview
Explore the financials of Scinex Corporation (2376.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Scinex Corporation (2376.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Scinex Corporation 2376.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.67B | $4.00B | $3.94B | $3.88B |
| Cost of Revenue | $2.80B | $2.63B | $2.44B | $2.35B |
| Gross Profit | $1.88B | $1.37B | $1.49B | $1.53B |
| Gross Profit Ratio | $0.40 | $0.34 | $0.38 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.46B | $1.42B | $1.46B | $1.45B |
| Operating Expenses | $1.46B | $1.42B | $1.46B | $1.45B |
| Total Costs & Expenses | $4.26B | $4.05B | $3.90B | $3.81B |
| Interest Income | $1.90M | $0.00 | $797000.00 | $27000.00 |
| Interest Expense | $3.39M | $0.00 | $3.66M | $3.59M |
| Depreciation & Amortization | $86.45M | $66.50M | $67.00M | $67.25M |
| EBITDA | $487.79M | $15.50M | $105.00M | $141.50M |
| EBITDA Ratio | $0.10 | $0.004 | $0.03 | $0.04 |
| Operating Income | $416.19M | -$52.00M | $38.00M | $75.00M |
| Operating Income Ratio | $0.09 | -$0.01 | $0.010 | $0.02 |
| Other Income/Expenses (Net) | -$18.24M | $65.00M | -$59.00M | $33.00M |
| Income Before Tax | $397.96M | $13.00M | -$21.00M | $108.00M |
| Income Before Tax Ratio | $0.09 | $0.003 | -$0.005 | $0.03 |
| Income Tax Expense | $175.37M | $9.00M | -$9.49M | $49.00M |
| Net Income | $222.59M | $4.00M | -$11.00M | $59.00M |
| Net Income Ratio | $0.05 | $0.001 | -$0.003 | $0.02 |
| EPS | $39.59 | $0.71 | -$1.96 | $10.52 |
| Diluted EPS | $39.59 | $0.71 | -$1.96 | $10.52 |
| Weighted Avg Shares Outstanding | $5.61M | $5.61M | $5.61M | $5.61M |
| Weighted Avg Shares Outstanding (Diluted) | $5.61M | $5.61M | $5.61M | $5.61M |
Over the last four quarters, Scinex Corporation achieved steady financial progress, growing revenue from $3.88B in Q1 2024 to $4.67B in Q4 2024. Gross profit stayed firm with margins at 40% in Q4 2024 versus 39% in Q1 2024. Operating income totaled $416.19M in Q4 2024, maintaining a 9% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $487.79M. Net income rose to $222.59M, with EPS at $39.59. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan